Ada Stewart, MD, shares strategies for primary care physicians to reduce patient anxiety and improve comfort during cervical cancer screening exams.

Nor does receiving a diabetes diagnosis guarantee optimal management as just one-fifth of people treated for the disease reached glycemic control in 2023.

Nerandomilast, with a PDUFA date of Q4 2025, leads the potential breakthrough therapies, with inhaled treprostinil and admilparant advancing quickly behind.

Exact Sciences launches Cancerguard™, a groundbreaking blood test for early cancer detection, aiming to transform cancer screening and save lives.

Although overall risk was just slightly elevated, study authors recommend alternative imaging methods when appropriate for women of childbearing age.

Your daily dose of the clinical news you may have missed.

Family physician Teresa Lovins, MD, highlights key community mental health resources primary care clinicians should know to support patients in crisis.

Expert discusses when to start screening, available test options, and recommended intervals for women aged 21 to 65 years.

Rocatinlimab offers promise as a novel T-cell rebalancing therapy that targets the OX40 receptor, with maintenance dosing as infrequently as every 8 weeks.

Northeastern states consistently ranked highest on measures including rates of flu vaccination across age groups, share of teens with current HPV and elders with shingles vaccination.